Chapter 1 - Gastro-intestinal System |
1.1 Dyspepsia & gastro-oesophageal reflux disease |
1.2 Antispasmodics |
1.3 Antisecretory drugs |
1.3.5 Proton pump inhibitors (PPI) |
1.3.5 Helicobacter pylori eradication |
1.4 Acute diarrhoea |
1.5 Chronic bowel disorders |
Guidance on assessing dehydration in children under 5 years |
1.6 Laxatives |
1.7 Local preparations for anal and rectal disorders |
Chapter 2 - Cardiovascular System |
2.1 Positive inotropic drugs |
2.2 Diuretics |
2.3 Anti-arrhythmic drugs |
2.4 Beta-adrenoreceptor blocking drugs |
2.5 Drugs affecting the renin-angiotensin system |
2.5 Summary of Antihypertensive Drug Treatment |
2.5 Care Pathway for Hypertension |
2.5 Prescribing Guidelines for Heart Failure Guidance |
2.6 Nitrates, CCBs and potassium channel activators |
2.6 Primary Care Guidelines for drug treatment of Chronic Stable Angina Pectoris |
2.6.3 Other antianginal drugs |
2.6.4 Peripheral vasodilators and related drugs |
2.8 Anticoagulant drugs |
2.8.2 Oral anticoagulants |
2.8.2 Drug Interactions for Apixaban, Dabigatran, Edoxaban and Rivaroxaban |
2.8.2 Decision aid for patients requiring stroke prevention in AF |
2.8.2 Reducing the risk of stroke in Atrial Fibrillation - NICE CG180 (including decision aid) |
2.8.2 NOAC Implementation priorities |
2.9 Antiplatelet drugs |
2.12 Lipid regulation |
2.12 Lipid regulating drugs |
Chapter 3 - Respiratory System |
3 Introduction |
Asthma Inhaler Pathways |
Asthma Step-down Guides |
Summary of recently introduced inhalers and their equivalents |
3.1 Bronchodilators |
3.2 Corticosteroids |
3.3.2 Leukotriene receptor antagonists |
Guidance for managing COPD |
3.4.1 - Antihistamines |
3.7 - Mucolytics |
Chapter 4 - Central Nervous System |
4.1 - Hypnotics and anxiolytics |
4.2 - Drugs used in psychoses and related disorders |
4.2.3 - Antimanic drugs |
4.3 - Antidepressants |
4.5 - CNS stimulants and drugs for ADHD |
4.5.1 - Drugs used in the treatment of obesity |
4.7 - Analgesics |
4.7.3 - Neuropathic pain |
4.7.4 - Antimigraine drugs |
4.8.1 - Epilepsy |
4.8.2 - Drugs used in status epilepticus |
4.10 - Drugs used in substance dependence |
4.11 - Drugs for dementia |
Chapter 5 - Infections |
link to Management of Infection Guidance for Primary Care |
5.1 - Antibacterial drugs |
5.2 - Antifungal drugs |
5.3 - Antiviral drugs |
Chapter 6 - Endocrine System |
6.1 - Drugs used in diabetes |
6.1.1 - Insulins |
6.1.2 - Drugs used in diabetes |
6.1 - Guidance on the use of Blood Glucose Testing Strips |
6.2 - Thyroid and anti-thyroid drugs |
6.3 - Corticosteriods |
6.4.1 - Hormone Replacement Therapy |
6.4.2 - Male sex hormones and antagonists |
6.5.2 - Posterior pituitary hormones and antagonists |
6.6 - Drugs affecting bone metabolism |
6.6 - Protocol for primary care management of patients prescribed PROLIA® (Denosumab) for prevention of fractures |
Chapter 7 - Obstetrics, Gynaecology and Urinary Tract Disorders |
7.2 - Treatment of vaginal and vulval conditions |
7.3 - Contraceptives |
7.3 - Consillient Pill Equivalences and VTE Risk |
7.4.1 - Drugs for urinary retention |
7.4.2 - Drugs for urinary frequency, enuresis and incontinence |
7.4.5 - Drugs for erectile dysfunction |
7.4.6 - Drugs for premature ejaculation |
Chapter 8 - Malignant Disease and Immunosuppression |
8.3 - Sex Hormones and Hormone Antagonists in Malignant Disease |
Chapter 9 - Nutrition and Blood |
9.1 - Anaemias and some other blood disorders |
9.2 - Fluids and electrolytes |
9.5 - Minerals |
9.6 - Vitamins |
Chapter 10 - Musculoskeletal and joint diseases |
10.1 – Drugs used in Rheumatic Disease and Gout |
10.1 – Treatment of Gout |
10.1- Management of Osteoarthritis |
Chapter 11 – Eye |
11.3 – Anti-infective eye preparations |
11.4 – Corticosteriods and other anti-inflammatory preparations |
11.5 – Mydriatics and Cycloplegics |
11.6 – Treatment of Glaucoma |
11.8 – Miscellaneous ophthalmic preparations |
Chapter 12 – Drugs acting on the Ear |
12.1 – Drugs acting on the Nose |
12.2 – Nasal Allergy |
12.3 – Drugs acting on the Oropharynx |
Chapter 13 – Skin |
13.2 – Emollient and barrier preparations guidance |
13.2.1 – Emollients |
3.2.1.1 – Emollient bath additives and shower preparations |
13.3 – Local Anaesthetics and Antipruritics |
13.4 – Topical corticosteriods |
13.5 – Preparations for Eczema and Psoriasis |
13.6.1 – Topical preparations for acne |
13.6.2 – Oral preparations for acne |
13.8 – Photodamage |
13.10 –Anti-infective skin preparations |
Chapter 15 – Anaesthesia |
15.1.7 – Antagonists for central and respiratory depression |